[Role of vascular nitric oxide in experimental liver cirrhosis].
Atucha
N M
NM
Departamento de Fisiología, Facultad de Medicina, Universidad de Murcia, Murcia.
Nadal
F J A
FJ
Iyu
D
D
García-Estañ
J
J
D000818:Animals; D001120:Arginine / Q000378:metabolism; D001652:Bile Ducts / Q000601:surgery; D002252:Carbon Tetrachloride Poisoning / Q000150:complications; D004351:Drug Resistance; D004730:Endothelium, Vascular / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006439:Hemodynamics; D006975:Hypertension, Portal / Q000209:etiology; D008026:Ligation; D008106:Liver Cirrhosis, Experimental / Q000209:etiology / Q000378:metabolism*; D009131:Muscle, Smooth, Vascular / Q000378:metabolism; D009569:Nitric Oxide / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III; D011169:Portal Vein / Q000601:surgery; D051381:Rats; D014662:Vasoconstrictor Agents / Q000494:pharmacology / Q000627:therapeutic use
D004791:Enzyme Inhibitors; D014662:Vasoconstrictor Agents; D009569:Nitric Oxide; D001120:Arginine; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III; C496318:Nos2 protein, rat; C496316:Nos3 protein, rat